Sylviane Poncelet

903 total citations
19 papers, 655 citations indexed

About

Sylviane Poncelet is a scholar working on Epidemiology, Immunology and Surgery. According to data from OpenAlex, Sylviane Poncelet has authored 19 papers receiving a total of 655 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Epidemiology, 8 papers in Immunology and 4 papers in Surgery. Recurrent topics in Sylviane Poncelet's work include Cervical Cancer and HPV Research (13 papers), Hepatitis B Virus Studies (11 papers) and Immunotherapy and Immune Responses (6 papers). Sylviane Poncelet is often cited by papers focused on Cervical Cancer and HPV Research (13 papers), Hepatitis B Virus Studies (11 papers) and Immunotherapy and Immune Responses (6 papers). Sylviane Poncelet collaborates with scholars based in Belgium, United States and Germany. Sylviane Poncelet's co-authors include Tino F. Schwarz, Francis Dessy, Sandra L. Giannini, Lígia A. Pinto, Troy J. Kemp, Marek Spaczyński, Gary Dubin, Dominique Descamps, Jacek Wysocki and Andrzej Gałaj and has published in prestigious journals such as The Journal of Infectious Diseases, Vaccine and Journal of Immunological Methods.

In The Last Decade

Sylviane Poncelet

18 papers receiving 629 citations

Peers

Sylviane Poncelet

EPIDE

IMMUN

SURGE

ASZ

Grégory Catteau Belgium

Katherine Giacoletti United States

Sara L. Bissett United Kingdom

Gail Barnum United States

Christine C. Roberts United States

Kevin C. Yim United States

Erica Borgogni Italy

Teresa Aydillo United States

Camilla Lagheden Sweden

Richard D. Wells United States

Grégory Catteau Belgium

Sylviane Poncelet

766 ×1.4

EPIDE

184 ×1.0

IMMUN

225 ×1.4

SURGE

79 ×1.0

ASZ

48 ×0.9

Citations per year, relative to Sylviane Poncelet Sylviane Poncelet (= 1×) peers Grégory Catteau

Countries citing papers authored by Sylviane Poncelet

Since Specialization

Citations

This map shows the geographic impact of Sylviane Poncelet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylviane Poncelet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylviane Poncelet more than expected).

Fields of papers citing papers by Sylviane Poncelet

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylviane Poncelet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylviane Poncelet. The network helps show where Sylviane Poncelet may publish in the future.

Co-authorship network of co-authors of Sylviane Poncelet

This figure shows the co-authorship network connecting the top 25 collaborators of Sylviane Poncelet. A scholar is included among the top collaborators of Sylviane Poncelet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylviane Poncelet. Sylviane Poncelet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Hu, Yuemei, Xiang Zhang, Yilin He, et al.. (2020). Long‐term persistence of immune response to the AS04‐adjuvanted HPV‐16/18 vaccine in Chinese girls aged 9‐17 years: Results from an 8‐9‐year follow‐up phase III open‐label study. Asia-Pacific Journal of Clinical Oncology. 16(6). 392–399. 1 indexed citations

Schwarz, Tino F., Li‐Min Huang, Alejandra Valencia, et al.. (2019). A ten-year study of immunogenicity and safety of the AS04-HPV-16/18 vaccine in adolescent girls aged 10-14 years. Human Vaccines & Immunotherapeutics. 15(7-8). 1970–1979. 45 indexed citations

Folschweiller, Nicolas, Ulrich Behre, Marc Dionne, et al.. (2019). Long-term Cross-reactivity Against Nonvaccine Human Papillomavirus Types 31 and 45 After 2- or 3-Dose Schedules of the AS04-Adjuvanted Human HPV-16/18 Vaccine. The Journal of Infectious Diseases. 219(11). 1799–1803. 12 indexed citations

Schwarz, Tino F., Andrzej Gałaj, Marek Spaczyński, et al.. (2017). Ten‐year immune persistence and safety of the HPV‐16/18 AS04‐adjuvanted vaccine in females vaccinated at 15–55 years of age. Cancer Medicine. 6(11). 2723–2731. 58 indexed citations

Robbins, Hilary A., Troy J. Kemp, Carolina Porras, et al.. (2014). Comparison of Antibody Responses to Human Papillomavirus Vaccination as Measured by Three Assays. Frontiers in Oncology. 3. 328–328. 21 indexed citations

Damme, Pierre Van, Geert Leroux‐Roels, Philippe Simon, et al.. (2014). Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from two randomized trials. Vaccine. 32(29). 3694–3705. 19 indexed citations

Robbins, Hilary A., Tim Waterboer, Carolina Porras, et al.. (2014). Immunogenicity assessment of HPV16/18 vaccine using the glutathione S-transferase L1 multiplex serology assay. Human Vaccines & Immunotherapeutics. 10(10). 2965–2974. 8 indexed citations

Dubin, Gary, Jean‐François Toussaint, Jean-Pol Cassart, et al.. (2013). Investigation of a regulatory agency enquiry into potential porcine circovirus type 1 contamination of the human rotavirus vaccine,Rotarix™. Human Vaccines & Immunotherapeutics. 9(11). 2398–2408. 31 indexed citations

Moscicki, A.-B., Cosette M. Wheeler, Barbara Romanowski, et al.. (2012). Immune responses elicited by a fourth dose of the HPV-16/18 AS04-adjuvanted vaccine in previously vaccinated adult women. Vaccine. 31(1). 234–241. 26 indexed citations

10.

Schwarz, Tino F., Marek Spaczyński, Achim Schneider, et al.. (2011). Persistence of immune response to HPV-16/18 AS04-adjuvanted cervical cancer vaccine in women aged 15-55 years. Human Vaccines. 7(9). 958–965. 33 indexed citations

11.

Schwarz, Tino F., Mariëlle Kocken, Tiina Petäjä, et al.. (2010). Correlation between levels of human papillomavirus (HPV)-16 and 18 antibodies in serum and cervicovaginal secretions in girls and women vaccinated with the HPV-16/18 AS04-adjuvanted vaccine. Human Vaccines. 6(12). 1054–1061. 38 indexed citations

12.

Kemp, Troy J., Alfonso Garcı́a-Piñeres, Roni T. Falk, et al.. (2008). Evaluation of systemic and mucosal anti-HPV16 and anti-HPV18 antibody responses from vaccinated women. Vaccine. 26(29-30). 3608–3616. 73 indexed citations

13.

Dessy, Francis, Sandra L. Giannini, Catherine Bougelet, et al.. (2008). Correlation between direct ELISA, single epitope-based inhibition ELISA and Pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine. Human Vaccines. 4(6). 425–434. 141 indexed citations

14.

Schwarz, Tino F., Marek Spaczyński, Achim Schneider, et al.. (2008). Immunogenicity and tolerability of an HPV-16/18 AS04-adjuvanted prophylactic cervical cancer vaccine in women aged 15–55 years. Vaccine. 27(4). 581–587. 129 indexed citations

15.

Limet, J. N., et al.. (1993). [Brucellosis among occupationally exposed people: evaluation of immunological tests after vaccination].. PubMed. 41(5). 457–62.

16.

Strady, A, F. Barrat, Sylviane Poncelet, et al.. (1992). [Brucella vaccination in professionally exposed subjects. Prospective study].. PubMed. 21(30). 1408–12. 2 indexed citations

17.

Collet-Cassart, D., et al.. (1991). Immunoturbidimetric assay of β2 microglobulin using latex particles in microplates. Journal of Immunological Methods. 142(2). 183–185. 2 indexed citations

18.

Poncelet, Sylviane, et al.. (1990). Immunoassay of Theophylline by Latex Particle Counting. Journal of Immunoassay. 11(1). 77–88. 11 indexed citations

19.

Collet-Cassart, D., et al.. (1989). A quantitative C-reactive protein assay using latex agglutination in microtiter plates. Journal of Immunological Methods. 125(1-2). 137–141. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact